Pharmacological blockade of glutamine transporter alanine-serine-cysteine transporter 2 (ASCT2), or glutaminolysis by V9302 or CB-839 effectively reverses osteoporosis induced by OVX [61, 62]. This evidence concerns the gene SLC1A5 and osteoporosis.